Cite
HARVARD Citation
Roth, S. et al. (2020). Next‐Generation DILI Biomarkers: Prioritization of Biomarkers for Qualification and Best Practices for Biospecimen Collection in Drug Development. Clinical pharmacology & therapeutics. 107 (2), pp. 333-346. [Online].